GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)

ADRCNew York Stock Exchange (XNYS)·USD

Identity

Security key: 16270
Ticker: GSK
Type: ADRC — American Depository Receipt Common
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 1976-08-18
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GSK

Detail

Enriched 2026-08-14 20:47

Market cap: $100,741,122,836.9
Shares outstanding (class): 2,022,697,682
Shares outstanding (weighted): 2,002,805,623
SIC: —
Employees: 66,841
Location: —
Homepage: https://www.gsk.com
Description: In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Market cap and share counts drift.

Funds holding this security

72 funds · 73 positions · $4.66B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
Dodge & Cox Stock Fund Dodge & Cox Funds	—	$2.37B	2.07%	42,980,277 NS	FIGI
VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS	—	$1.00B	1.38%	18,147,650 NS	FIGI
Fidelity Series Large Cap Stock Fund Fidelity Hastings Street Trust	—	$248.37M	1.00%	4,500,328 NS	FIGI
Dodge & Cox Balanced Fund Dodge & Cox Funds	—	$233.75M	1.60%	4,235,395 NS	FIGI
VANGUARD PRIMECAP CORE FUND VANGUARD FENWAY FUNDS	—	$195.60M	1.44%	3,544,080 NS	FIGI
Fidelity Advisor Capital Development Fund Fidelity Destiny Portfolios	—	$59.41M	1.04%	1,076,500 NS	FIGI
VanEck Pharmaceutical ETF VanEck ETF Trust	PPH	$58.86M	4.58%	1,066,504 NS	FIGI
Fidelity Mega Cap Stock Fund Fidelity Hastings Street Trust	—	$57.25M	0.95%	1,037,266 NS	FIGI
Fidelity Enhanced International ETF Fidelity Covington Trust	FENI	$50.89M	0.63%	922,000 NS	FIGI
JNL/WMC Balanced Fund JNL Series Trust	—	$42.11M	0.48%	763,003 NS	FIGI
First Trust Value Line Dividend Index Fund First Trust Exchange-Traded Fund	FVD	$35.99M	0.44%	652,145 NS	FIGI
VIP Growth and Income Portfolio Variable Insurance Products Fund III	—	$35.11M	1.33%	636,235 NS	FIGI
CAPITAL GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS	—	$32.13M	1.39%	582,200 NS	FIGI
VIP Contrafund Portfolio Variable Insurance Products Fund II	—	$31.86M	0.12%	577,300 NS	FIGI
Fundamental Large Cap Value Trust John Hancock Variable Insurance Trust	—	$23.85M	2.95%	432,069 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGSK
FIGI_COMPOSITEBBG000BLB481
FIGI_SHARE_CLASSBBG001SD6SM6
CIK0001131399
ISINUS37733W2044
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: GSK is a global pharmaceutical company, so it falls under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.